Maintaining and Assessing High-Quality hPSC Cultures
hPSCs hold tremendous promise in a wide range of applications, including regenerative medicine, disease modeling, drug discovery and toxicology. Advancing in popularity alongside CRISPR-Cas9 genome editing, these technologies are being used in combination to generate novel data at a rapid pace. Now that the first clinical trials involving differentiated derivatives of hPSCs are underway, it is only a matter of time before genetically modified hPSC lines are being assessed for their suitability in clinical applications. As a result, there is a renewed focus on cell quality. In this webinar, our in-house experts Dr. Andrew Gaffney and Dr. Adam Hirst discuss how you can maintain and assess high-quality hPSC cultures throughout the various stages of your research.
Publish Date:
March 12, 2018
Related Multimedia
-
Genetic Stability of Human Pluripotent Stem Cells
Publish Date: October 06, 2016 -
Whole Exome Sequencing Reveals Selective Pressures and Dominant Negative Mutations in hPSC Cultures
Publish Date: April 19, 2017 -
Using CRISPR/Cas9 to Model Stem Cell Organization and Dynamics
Publish Date: August 25, 2017 -
Data Quality and Standards for Pluripotent Stem Cells
Publish Date: September 28, 2018
Explore Our Products
-
Defined medium for naïve-like human pluripotent stem cells -
Defined supplement for single-cell cloning of human ES and iPS cells -
cGMP, feeder-free maintenance medium for human ES and iPS cells -
qPCR analysis kit for detecting the majority of karyotypic abnormalities reported in human ES and iPS cells
